Is there a link between inflammation and fatigue in multiple sclerosis?

Abstract

PurposeAmong autoimmune diseases of the central nervous system stands multiple sclerosis (MS), which is characterized by demyelination, synaptopathy, and neurodegeneration. MS fatigue can affect up to 90% of patients and be very disabling, with a drastic impact on their quality of life. To date, the evaluation of MS fatigue has relied mainly on subjective scales, and actual therapeutic interventions are challenged by modest efficacy and numerous undesirable effects. Therefore, finding biomarkers of MS fatigue might help in optimizing evaluation and treatment strategies. The main objective here was to assess the relationship between MS fatigue and inflammatory or other immunomediated markers.MethodsResearch was conducted according to PRISMA guidelines. Computerized databases (ie, PubMed/Medline and Scopus) were consulted till February 2018 aiming to identify articles that addressed inflammation and MS fatigue. Studies in English and French published at any time were considered.ResultsA total of 27 studies matched the research criteria. Inconsistency existed regarding the relationship between fatigue and the orexin A system, hypothalamus–pituitary–adrenal axis, and cerebrospinal fluid inflammatory markers. As for peripheral markers, although there was scarcity in the available data, serum proinflammatory cytokines (ie, IL6, TNFα, and IFNγ) seem to be associated with MS fatigue. Finally, no link was found between MS fatigue and T-cell populations (ie, CD3+CD4+ T lymphocytes, regulatory T cells) or other peripheral markers of inflammation (ie, CRP, erythrocyte-sedimentation rate, soluble ICAM1).ConclusionFuture large-scale studies would benefit from comparing the relationship between fatigue and immune measures in patients with different disease phenotypes with and without disease-modifying drugs. With the subjective nature of fatigue scales, finding objective biomarkers for fatigue would be of great help.

Biomarkers and Disease Activity in Multiple Sclerosis : A cohort study on patients with clinically isolated syndrome and relapsing remitting multiple sclerosis

“…MRI and EDSS assessments do not well reflect fatigue experience in MS patients [84]. Possible links between inflammation and fatigue in MS have been suggested [86] but although IL-6 [87][88][89] has been implicated, its association with fatigue is not firmly established and published data on NFL, CXCL1, CXCL10 and CXCL13 levels in CSF in relation to fatigue scores are lacking. Treatment of fatigue mainly involves non-pharmacological interventions, e.g.…”

Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis – Randomized clinical trial

“…The central nervous system (CNS) can be affected by numerous adverse conditions, such as multiple sclerosis (MS), which is an autoimmune disease classified as the second most common cause of physical disability, especially among young individuals. [1,2] One of the prominent characteristics of MS is the infiltration of Th1 lymphocytes from peripheral blood into the brain and spinal cord, leading to the activation of microglia. [3] Microglia play an important role in MS and are capable of differentiating into two phenotypes: M1 (pro-inflammatory) and M2 (anti-inflammatory).…”

Fadiga e Disfagia Orofaríngea em Pacientes com Esclerose Múltipla

“…A evolução da doença, gravidade e seus sintomas são variáveis e acometem de forma diferente cada indivíduo. Aparentemente as formas progressivas da EM podem estar mais relacionadas à destruição axonal, já as formas remitente-recorrente (EMRR) à desmielinização da bainha de mielina, levando a uma variedade de sintomas 6 . A forma remitente-recorrente é a mais comum, na qual ocorrem surtos que duram dias ou semanas, com remissão dos sintomas 7 .…”